Company attributes
B2X
Founder
Legal Name
Isomerase Therapeutics Ltd.
Legal classification
Date Incorporated
2012
Number of Employees (Ranges)
11 – 50
Phone Number
+441223911856
Full Address
Suite 9 Science Village Chesterford Research Park, Little Chesterford SAFFRON WALDEN , CB10 1XL United Kingdom
Founded Date
2012
Latest Funding Round Date
August 2016
Latest Funding Type
Patents Assigned (Count)
2
Country
Other attributes
Company Operating Status
Active
Wikidata ID
Isomerase Therapeutics is an agile drug discovery and development company based in Cambridge, UK and is a leader in the discovery and development of compounds that target molecules such as cyclophilins. The Company is led by an experienced team with a successful track record in the discovery, development and commercialization of drugs by applying a combination of biosynthetic engineering and synthetic chemistry.
Isomerase Therapeutics received a Queens Award for Enterprise in 2017.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
